WOLLENBERG, A.; HOWELL, M. D.; GUTTMAN-YASSKY, E.; SILVERBERG, J. I.; BIRRELL, C.; KELL, C.; RANADE, K.; DAWSON, M.; VAN DER MERWE, R. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S29, 2018. DOI: 10.25251/skin.2.supp.28. Disponível em: https://jofskin.org/index.php/skin/article/view/281. Acesso em: 22 jul. 2024.